November 2016 - Copenhagen, Denmark
Meeting objectives:
- Provide an overview of the health care systems and vaccination programs.
- Review the epidemiological situation of HPV infection and related diseases.
- Give an overview of the current prevention and control measures on HPV.
- Discuss the challenges and the progress achieved in HPV prevention.
- Review the possible implementation of new prevention strategies, control measures and monitoring systems.
- Discuss the successes, issues and barriers to overcome, and the way forward.
Background document (pdf, 14MB)
NOVEMBER 17, 2016
SESSION 1: WECLOMING AND REVIEW OF THE MEETING OBJECTIVES
Chairs: Robb Butler & Palle Valentiner-Branth
- Welcome by Director of the Division of Health Emergencies and Communicable Diseases (DEC)
Nedret Emiroglu, WHO EURO
- Welcome and review of the meeting objectives and programme
Alex Vorsters, University of Antwerp
SESSION 2: The Danish Health Care System
- The Danish health care system and overview of all vaccinations programs (pdf, 761 kB)
Camilla Rosengaard Villumsen, Ministry of Health (Denmark)
SESSION 3: Epidemiology, burden of disease and surveillance
- Epidemiology of HPV and burden of HPV-related neoplasia in Denmark
Susanne Krüger Kjær, Ringshospitalet & Danish Cancer Society (Denmark)
- HPV surveillance (pdf, 1.1 MB)
Christian Munk, Danish Cancer Society (Denmark)
- Monitoring adverse events following immunization with HPV-vaccines in Denmark (pdf, 868 kB)
Line Michan, Danish Medicines Agency (Denmark)
- Questions & discussion.
SESSION 4: PREVENTION AND CONTROL OF HPV IN DENMARK
Chairs: Kate Cuschieri & Kåre Mølbak
- HPV vaccination programmes in Denmark (pdf, 336 kB)
Palle Valentiner-Branth, Statens Serum Institut (Denmark)
- Cervical cancer screening programmes in Denmark
Elsebeth Lynge, University of Copenhagen (Denmark)
- Home sampling for hrHPV testing in Central Denmark Region (pdf, 1.4 MB)
Berit Andersen, Regionshospitalet Randers (Denmark)
- Questions & discussion
Chairs: Susan Wang & Scott Wittet
- Cervical cancer treatment and late effects (pdf, 2.3 MB)
Pernille Tine Jensen, Odense University Hospital (Denmark)
SESSION 5: ACHIEVEMENTS AND CHALLENGES IN DENMARK AND LESSONS LEARNT
- The case of POTS (pdf, 2. 8 MB)
Jesper Mehlsen, Bispebjerg Hospital, Frederiksberg (Denmark)
- Care-seeking in females reporting severe adverse reactions to HPV vaccine: Research and policy perspectives (pdf, 660 kB)
Kåre Mølbak, Statens Serum Institute (Denmark)
- Progress achieved – real world impact from a Danish perspective
Susanne Krûger Kjaer
- Evidence-based general practice: prevention among healthy people (pdf, 415 kB)
John Brodersen, Centre of Research & Education in General Practice (Denmark)
- Danish Cancer Society initiatives and the background for the initiatives (1.4 MB)
Ulla Axelsen, Ringshospitalet and Danish Cancer Society (Denmark)
- Danish Health Authority: possible efforts to increase HPV vaccine uptake
Bolette Søborg, Danish National Board of Health (Denmark)
Chair and moderator: Margaret Stanley
- Panel discussion.
Panel: Ulla Axelsen, Susanne Krûger Kjaer, Kåre Mølbak,
Jesper Mehlsen, Bolette Søborg, John Brodersen
- Conclusions of the day
NOVEMBER 18, 2016
SESSION 6: GLOBAL ACHIEVEMENTS AND CHALLENGES
Chairs: Emilie Karafillakis & Elsebeth Lynge
- HPV Programs at a global level (pdf, 2.2 MB)
Ikechukwu Ogbuanu, WHO
- What can we learn from HepB vaccine and other vaccine safety issues? (pdf, 1.4 MB)
Mark Kane, consultant
- Questions & discussion
SESSION 7: THE WAY FORWARD
Chairs: Pierre Van Damme & Camilla Rosengaard Villumsen
- The way forward in Denmark & lessons learnt for the rest of the world: Discussion in working groups
- The way forward in Denmark & lessons learnt for the rest of the world: Plenary: results from the working groups
SESSION 8: CONCLUSIONS OF THE MEETING
Chairs: Silvia de Sanjosé & Bolette Søborg
- Presentation of the meeting conclusions & feedback.
Marc Baay